Levacetylleucine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Levacetylleucine. Educational only — not medical advice.
Labeled uses
AQNEURSA™ is indicated for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing ≥15 kg.
Source: FDA labeling via NIH DailyMed (set 0f248e55…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.